JP2013538819A - ランチビオチックペプチド系アポトーシスイメージング剤 - Google Patents

ランチビオチックペプチド系アポトーシスイメージング剤 Download PDF

Info

Publication number
JP2013538819A
JP2013538819A JP2013529674A JP2013529674A JP2013538819A JP 2013538819 A JP2013538819 A JP 2013538819A JP 2013529674 A JP2013529674 A JP 2013529674A JP 2013529674 A JP2013529674 A JP 2013529674A JP 2013538819 A JP2013538819 A JP 2013538819A
Authority
JP
Japan
Prior art keywords
chelator
imaging agent
conjugate
lbp
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013529674A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013538819A5 (enExample
Inventor
インドレヴォル,バード
ヒスコック,ダンカン
アーボ,ベンテ・エリザベス
ヴァラ,ラジヴ
グレイザー,マティアス・エバーバード
マクロビー,グラハム・ウォルター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of JP2013538819A publication Critical patent/JP2013538819A/ja
Publication of JP2013538819A5 publication Critical patent/JP2013538819A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2013529674A 2010-09-27 2011-09-27 ランチビオチックペプチド系アポトーシスイメージング剤 Withdrawn JP2013538819A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1016206.3 2010-09-27
GBGB1016206.3A GB201016206D0 (en) 2010-09-27 2010-09-27 Apoptosis imaging agents
PCT/EP2011/066789 WO2012041862A1 (en) 2010-09-27 2011-09-27 Apoptosis imaging agents based on lantibiotic peptides

Publications (2)

Publication Number Publication Date
JP2013538819A true JP2013538819A (ja) 2013-10-17
JP2013538819A5 JP2013538819A5 (enExample) 2014-11-13

Family

ID=43128013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013529674A Withdrawn JP2013538819A (ja) 2010-09-27 2011-09-27 ランチビオチックペプチド系アポトーシスイメージング剤

Country Status (13)

Country Link
US (1) US20130189186A1 (enExample)
EP (1) EP2621545A1 (enExample)
JP (1) JP2013538819A (enExample)
KR (1) KR20130097780A (enExample)
CN (1) CN103118710A (enExample)
AU (1) AU2011310663A1 (enExample)
BR (1) BR112013006536A2 (enExample)
CA (1) CA2810573A1 (enExample)
GB (1) GB201016206D0 (enExample)
MX (1) MX2013003398A (enExample)
RU (1) RU2013113677A (enExample)
SG (1) SG188464A1 (enExample)
WO (1) WO2012041862A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108144073A (zh) * 2017-12-28 2018-06-12 中山大学附属第医院 靶向磷脂酰乙醇胺的放射性标记三聚乙二醇修饰耐久霉素多肽药物
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
EP4057002B1 (en) 2019-11-12 2024-08-07 Ewha University-Industry Collaboration Foundation Cell imaging composition and cellular material imaging method using same
CN113368264B (zh) * 2020-03-09 2022-09-30 南方医科大学南方医院 放射性标记肉桂霉素,其制备方法及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
US7034113B2 (en) * 2002-02-22 2006-04-25 Paradigm Diagnostics, Llc Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
US7879801B2 (en) 2002-07-15 2011-02-01 Board Of Regents, The University Of Texas System Compositions comprising cell-impermeant duramycin derivatives
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
US20060110323A1 (en) 2004-11-19 2006-05-25 Ming Zhao Method of imaging cell death in vivo
AU2009223677A1 (en) 2008-03-10 2009-09-17 Mcw Research Foundation, Inc. 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical

Also Published As

Publication number Publication date
SG188464A1 (en) 2013-04-30
US20130189186A1 (en) 2013-07-25
MX2013003398A (es) 2013-05-30
KR20130097780A (ko) 2013-09-03
BR112013006536A2 (pt) 2016-05-31
AU2011310663A1 (en) 2013-03-28
EP2621545A1 (en) 2013-08-07
GB201016206D0 (en) 2010-11-10
WO2012041862A1 (en) 2012-04-05
CA2810573A1 (en) 2012-04-05
RU2013113677A (ru) 2014-11-10
CN103118710A (zh) 2013-05-22

Similar Documents

Publication Publication Date Title
JP7194161B2 (ja) 前立腺特異的膜抗原(psma)の標識インヒビター、前立腺癌の治療のための画像化剤および薬剤としてのその使用
CN101454026B (zh) 成像剂
JP3558169B2 (ja) 新規化合物及びその製造方法並びに診断用薬剤
JP2014505021A (ja) アポトーシス用petイメージング剤
JP2005500325A (ja) 改良キレート剤結合体
JP2009518372A (ja) 線維症用の新規造影剤
JP5961191B2 (ja) テクネチウム標識ペプチド
JP2013538819A (ja) ランチビオチックペプチド系アポトーシスイメージング剤
JP6280507B2 (ja) キレート剤
EP4651910A1 (en) Dual labelled compounds targeting the prostate specific membrane antigen
HK40080502B (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
HK40010018A (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
HK40001785A (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
Hueting Radiolabelled copper complexes for cancer imaging
HK1221711B (zh) 前列腺特异性膜抗原(psma)的标记的抑制剂,它们作为显影剂和用於治疗前列腺癌的药剂的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140926

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140926

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20141104